Clinical evaluation of the effect of siddha classical drug MANDOORA ADAI KIYAZHAM for the treatment of VATHASOOBAI

Clinical evaluation of the effect of MANDOORA ADAI KIYAZHAM for the treatment of VATHASOOBAI

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/030071

Enrollment

Registered

2020-12-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: MANDOORA ADAI KIYAZHAM: Should be administered orally twice a day after food for a period of 30 days Dose 15 to 30 ml Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: subjects with following symptoms will be included in the study 1 oedema due to protein deficiency 2 oedema due to iron deficiency 3 oedema due to renal impairment

Exclusion criteria

Exclusion criteria: 1 Hypothyroidism 2 Cushing syndrome 3 Oedema due to drug allergy 4 Oedema mimics obesity in children

Design outcomes

Primary

Measure	Time frame
Reduces the symptoms of Pallor eyes and lips Generalized OedemaTimepoint: 10 days	—

Secondary

Measure	Time frame
Assessment based on specific test Total Haemoglobin RFT Plasma protein Urine Albumin Micro albuminTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr D K Soundararajan MDs

Government Siddha Medical College and Hospital Palayamkottai Tirunelveli

dr.dks2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026